Steven Cohen Organon & Co. Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$10.95 - $17.32 $34.8 Million - $55.1 Million
3,179,778 Added 35244.71%
3,188,800 $46 Million
Q3 2023

Nov 14, 2023
BUY
$16.59 - $23.77 $149,674 - $214,452
9,022 New
9,022 $156,000
Q1 2023

May 15, 2023
BUY
$21.42 - $32.08 $755,269 - $1.13 Million
35,260 New
35,260 $829,000

Others Institutions Holding OGN

# of Institutions
794
Shares Held
202M
Call Options Held
1.71M
Put Options Held
865K
View Full List

About Organon & Co.

OGN Quotes by TradingView
  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.03B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email